Biotest Aktiengesellschaft
Save
1.87B
Market cap
Current P/E
476.19x
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas.

Similar securities

Based on sector and market capitalization

Report issue